INFLUENCE OF THE HOST RELATED FACTORS IN THE DEVELOPMENT OF THE HEPATOSPLENIC FORM OF SCHISTOSOMIASIS-MANSONI

被引:11
作者
PRATA, A
机构
[1] Disciplina de Doenças Infecciosas e Parasitárias, Faculdade de Medicina do Triângulo Mineiro, MG, Brasil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 1992年 / 87卷
关键词
SCHISTOSOMIASIS MANSONI; HEPATOSPLENIC FORM; HOST FACTORS;
D O I
10.1590/S0074-02761992000800005
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The frequency of hepatosplenomegaly in endemic areas is not proportional to the fecal ova count. This may be explained by epidemiological genetic. The occurrence of two or more cases of schistosomal hepatosplenomegaly in nuclear family is much higher than expected. The concentration is higher among siblings than it is among mothers and children of father and children. It is not significant between father and mother. If the mother, instead of the father, has hepatosplenic schistosomiasis the relative risk for the child to acquire hepatosplenomegaly is at least five times (the maternal affect). The inbreeding is higler in the hepatosplenic than in the hepatointestinal patients. In some areas in Brazil the hepatosplenic form of the schistosomiasis mansoni occurs with much higher frequency in whites than in blacks. After treatment, reversion of hepatosplenic schistosomiasis occurs more frequently in non-whithers. It seems that the resistance of blacks to the hepatosplenic form of schistosomiasis may be related to the glyoxalase system, perhaps associated to another genetic marker. The hepatosplenic schistosomiasis is less frequent in longilineal individuals. In some areas the hepatosplenic form of schistosomiasis is more frequent in A blood group of ABO sistem. The family heredograms do not suggest a single mendelian inheritance, but probably a multifactorial and possibly poligenic one.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 40 条
[1]  
ABAZA H, 1985, TISSUE ANTIGENS, V26, P7
[2]  
ABDELSALAM E, 1986, TISSUE ANTIGENS, V27, P142, DOI 10.1111/j.1399-0039.1986.tb01513.x
[3]  
ABDELSALAM E, 1979, J IMMUNOL, V123, P1829
[4]  
ABEL L, 1991, AM J HUM GENET, V48, P959
[5]  
BEIGUELMAN B, 1983, REV BRAS GENET, V6, P109
[6]   IMMUNITY AFTER TREATMENT OF HUMAN SCHISTOSOMIASIS MANSONI .2. IDENTIFICATION OF RESISTANT INDIVIDUALS, AND ANALYSIS OF THEIR IMMUNE-RESPONSES [J].
BUTTERWORTH, AE ;
CAPRON, M ;
CORDINGLEY, JS ;
DALTON, PR ;
DUNNE, DW ;
KARIUKI, HC ;
KIMANI, G ;
KOECH, D ;
MUGAMBI, M ;
OUMA, JH ;
PRENTICE, MA ;
RICHARDSON, BA ;
SIONGOK, TKA ;
STURROCK, RF ;
TAYLOR, DW .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1985, 79 (03) :393-408
[7]   A, B, O BLOOD-GROUPS AND CLINICAL FORMS OF SCHISTOSOMIASIS MANSONI [J].
CAMUS, D ;
BINA, JC ;
CARLIER, Y ;
SANTORO, F .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1977, 71 (02) :182-182
[8]  
CARDOSO W, 1953, Med Cir Farm, V202-203, P89
[9]   SCHISTOSOMA-MANSONI AND S-HAEMATOBIUM INFECTIONS IN EGYPT .2. QUANTITATIVE PARASITOLOGICAL FINDINGS AT NECROPSY [J].
CHEEVER, AW ;
KAMEL, IA ;
ELWI, AM ;
MOSIMANN, JE ;
DANNER, R .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1977, 26 (04) :702-716
[10]  
CONCEICAO MJ, 1980, REV SOC BRAS MED TRO, V13, P17